All articles tagged: Acute bronchiolitis due to respiratory syncytial virus (J21.0)

Nirsevimab therapy is effective for reducing the risk for hospitalization for respiratory syncytial virus (RSV)-associated bronchiolitis among infants, according to a study published in the July 11 issue of the New England Journal of Medicine.Zein Assad, M.D., from the Robert Debré University Hospital in Paris, and colleagues conduct

In new vaccination guidance issued Wednesday, U.S. health officials now recommend that all Americans aged 75 and older get an RSV vaccine before fall arrives.However, those a bit younger -- ages 60 to 74 -- should only seek the shot if they are vulnerable to severe RSV because of chronic medical conditions such as lung or heart disease, or if

Wastewater testing is effective in detecting infections like mpox, with a 32% likelihood of detection. It's a valuable tool for early disease detection and monitoring, including COVID-19, and will expand to track antibiotic-resistant germs and food poisoning bugs.

For the first time in months, there has been "a single-week decrease" in flu activity, according to data released by the U.S. Centers for Disease Control and Prevention.But health officials warn that the flu season is far from over, with a surge expected shortly. "Folks try not to seek care

CDC warns of rising respiratory virus cases in the US, driven by increased COVID-19 hospitalizations, especially among children, and a surge in flu and RSV cases. Low vaccination rates remain a concern.

The JN.1 variant, a descendant of the variant BA.2.86, now accounts for 44 percent of COVID-19 cases, up from roughly 7 percent in late November, the latest data from the U.S. Centers for Disease Control and Prevention show.The speed at which the JN.1 variant has sprea

Nirsevimab is efficacious for preventing hospitalization for respiratory syncytial virus (RSV)-associated lower respiratory tract infection among infants, according to a study published in the Dec. 28 issue of the New England Journal of Medicine.Simon B. Drysdale, Ph.D., from the Centre for Neonatal and Paediatric Infections at the Un

Many nursing home residents and adults have not been vaccinated for influenza, COVID-19, or respiratory syncytial virus (RSV) for the 2023 to 2024 season, according to research published in the Dec. 22 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.Hannah E. Reses, M.P.H., from the C

A single dose of mRNA-1345 vaccine is safe and results in lower incidence of respiratory syncytial virus (RSV)-associated disease in older patients, according to a study published in the Dec. 14 issue of the New England Journal of Medicine.Eleanor Wilson, M.D., from Moderna in Cambridge, Massachusetts, and colleagues conducted a rando

The World Health Organization (WHO) is seeking more information from China about a rise in respiratory illnesses and pneumonia in children, following the lifting of COVID-19 restrictions. This increase is linked to various pathogens, including influenza and RSV. There are also reports of undiagnosed pediatric pneumonia cases in northern China. The WHO has requested detailed data from China and adv

During the COVID-19 pandemic era, pediatric bronchiolitis hospitalizations decreased transiently, then increased, according to a study published online Oct. 26 in JAMA Network Open.Kailey A. Remien, D.O., from Akron Children's Hospital in Ohio, and colleagues conducted a retrospective cross-sectional study using data from 41 U.S. childr

The annual meeting of the Infectious Diseases Society of America was held this year from Oct. 11 to 15 in Boston and attracted participants from around the world, including scientists, physicians, and other health care professionals. The conference featured education courses and comprehensive educational programs that focused on the latest advances in the d